INTERVIEWS: New HPV Research & Cervical Cancer Prevention (Photo) - 01/28/26

PORTLAND, Ore. (January 28, 2026) ~ January is Cervical Health Awareness Month, a time to highlight prevention and address persistent myths around Human papillomavirus (HPV), vaccination, and cervical cancer screening. Kaiser Permanente Northwest is offering interviews with Amanda Petrik, PhD, a Portland-based researcher whose work focuses on increasing education about the HPV virus, expanding access to HPV prevention, and reducing long-standing disparities in cervical cancer outcomes.

HPV causes cervical cancer and is also linked to six other cancers, including anal, oropharyngeal (mouth and throat), penile, vulvar, and vaginal cancers. The HPV vaccine is an effective cancer-prevention vaccine available today for both females and males. Yet screening gaps remain: more than half of cervical cancer cases occur among people who were never or rarely screened, with lower screening rates in safety-net clinics that serve low-income and racially diverse populations.

“Cervical cancer is largely preventable, but prevention only works if people can access tools that fit their lives,” said Amanda Petrik, PhD, investigator with the Kaiser Permanente Center for Health Research in Portland. “Whether it’s expanding HPV vaccination in school-based health centers or offering self-collected screening as an alternative to a Pap test, our goal is to reduce barriers and prevent cancer before it starts.”

Dr. Petrik is a health services researcher with more than 20 years of experience studying health systems, policy, and cancer prevention in real-world settings, including community and safety-net clinics. Her current National Cancer Institute-funded study, STEP-2, is testing FDA-approved HPV self-sampling kits as a cervical cancer screening option for patients who are due or overdue for screening. The study aims to identify the most effective and cost-efficient ways to implement programs that increase screening rates and reduce disparities as the technology rolls out nationally.

Interviews available:

Amanda Petrik, PhD, health services researcher with the Kaiser Permanente Center for Health Research, is available for interviews on Thursday, Jan. 29 from 9-10 a.m. and 11-12:30 p.m. Contact Karen Vitt to schedule.

Dr. Petrik is prepared to discuss:

• How the HPV vaccine protects against HPV virus and multiple cancers

• Who should get the HPV vaccine and when it’s typically recommended (age 9)

• How HPV self-collection (cervical cancer screening) works and why it may improve screening rates

• Disparities in cervical cancer screening and outcomes

• What Cervical Health Awareness Month means for prevention and public health

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve nearly 12.6 million members in 8 states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists, and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery, and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education, and the support of community health. For more information, please visit: about.kaiserpermanente.org.